Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 16:00 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00112684 · National Cancer Institute (NCI) · PHASE1 · terminated · last registry update 2014-02-24 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, National Cancer Institute (NCI) |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CDK2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-02-04Also stopped (terminated): Merck Sharp & Dohme LLC, SCH 727965 + Gemtuzumab ozogamicin (NCT00798213)
- 2014-01-21Results posted on the registry: National Cancer Institute (NCI), alvocidib + irinotecan hydrochloride (NCT00991952)
- 2014-01-10Results posted on the registry: National Cancer Institute (NCI), alvocidib + docetaxel (NCT00331682)
- 2013-12-16Also stopped (terminated): National Cancer Institute (NCI), alvocidib (NCT00070239)
- 2013-12-05Results posted on the registry: National Cancer Institute (NCI), alvocidib + mitoxantrone hydrochloride (NCT00795002)
- 2013-07-09Also stopped (terminated): National Cancer Institute (NCI), 7-hydroxystaurosporine + cisplatin (NCT00012194)
- 2013-07-02Also stopped (terminated): National Cancer Institute (NCI), alvocidib (NCT00377104)
- 2013-06-04Also stopped (terminated): National Cancer Institute (NCI), alvocidib (NCT00101231)
- 2013-05-14Results posted on the registry: National Cancer Institute (NCI), cisplatin + alvocidib (NCT00083122)
- 2013-02-25Results posted on the registry: National Cancer Institute (NCI), dinaciclib (NCT01096342)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision